<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>611</ReferenceId>
        <DateLastUpdated>2020-10-11-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15178254</PubmedId>
            <Abstract>Multi-disciplinary studies of fluorescein-protein conjugates have led to the generation of a family of antibodies with common idiotypes and affinities for fluorescein ranging over five orders of magnitude. The high affinity 4-4-20 prototype traps the ligand in a highly complementary binding slot, which is lined by multiple aromatic side-chains. An antibody (9-40) of intermediate affinity belongs to the same idiotypic family as 4-4-20 and shares substantial amino acid identities within the VL and VH domains. To establish the structural basis for the affinity differences, we solved the crystal structure of the 9-40 Fab-fluorescein complex at a resolution of 2.3A. Similar to 4-4-20, 9-40 binds fluorescein in a tight aromatic slot with its xanthenonyl ring system accommodated by end-on insertion. However, the combined effects of the amino acid substitutions have resulted in reorganization of the binding site, with the HCDR3 loops showing the greatest differences in conformations. Access to the binding site of 9-40 is substantially more open, leaving the fluorescein's phenylcarboxylate moiety partially exposed to solvent. In addition to the usage of a different D (diversity) mini-gene encoding the HCDR3 loop, the decrease in fluorescein affinity in the 9-40 antibody family appears to be correlated with the substitution of histidine (9-40) for arginine (4-4-20) in position 34 of the antibody light chains.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>1141-51</ArticlePages>
            <ArticleTitle>Three-dimensional structures of idiotypically related Fabs with intermediate and high affinity for fluorescein.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Terzyan</LastName>
                    <ForeName>Simon</ForeName>
                </Author>
                <Author>
                    <LastName>Ramsland</LastName>
                    <ForeName>Paul A</ForeName>
                </Author>
                <Author>
                    <LastName>Voss</LastName>
                    <ForeName>Edward W</ForeName>
                    <Suffix>Jr</Suffix>
                </Author>
                <Author>
                    <LastName>Herron</LastName>
                    <ForeName>James N</ForeName>
                </Author>
                <Author>
                    <LastName>Edmundson</LastName>
                    <ForeName>Allen B</ForeName>
                </Author>
            </Authors>
            <Affiliations>Crystallography Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.</Affiliations>
            <ArticleChemicalList>Immunoglobulin Fab Fragments;Immunoglobulin Idiotypes;Macromolecular Substances;Fluorescein</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Binding Sites, Antibody; Crystallography, X-Ray; Fluorescein(chemistry; metabolism); Immunoglobulin Fab Fragments(chemistry; metabolism); Immunoglobulin Idiotypes; Macromolecular Substances; Models, Molecular; Molecular Sequence Data; Protein Conformation; Sequence Alignment</ArticleMeshHeadingsList>
            <Journal>
                <Volume>339</Volume>
                <Issue>5</Issue>
                <Title>Journal of molecular biology</Title>
                <Issn>1089-8638</Issn>
                <MedlineTa>J Mol Biol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>fluorescein</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:31624</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Materials and Methods and PDB 1T66</LocationOfData>
                <EpitopeId>137337</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1, Figures 2, 3, 4 and PDB 1T66</LocationOfData>
                        <BCellId>5736</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <AccessionNonSequenceMolecule>
                                            <ChemicalType>Other Non-Sequence</ChemicalType>
                                            <Molecule>
                                                <ChEBIId>CHEBI:31624</ChEBIId>
                                            </Molecule>
                                        </AccessionNonSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>fluorescein</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference cited: Bates et al. (1985) Mol Immunol. 22(8):871-877 [PMID: 3930950].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.3</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The intact 9-40 antibody was derived from the same idiotypic family as 4-4-20 (see complex of 4-4-20 Fab with fluorescein PDB ID 4fab) but was altered by fewer somatic mutations in the germline genes which led to a 1000-fold reduction in affinity for fluorescein by 9-40 relative to 4-4-20.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-fluorescein 9-40</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>9-40 Fab</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1T66_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1T66_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>fluorescein</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:31624</ChEBIId>
                                        </Molecule>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1T66</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>L</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>L: (FLU)300</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: Y32:H1, W33:H1, R52:H2, N53:H2, Y56:H2, G102:H3, Y103:H3, H104:H3; L: H31:L1, N33:L1, N35:L1, Y37:L1, H39:L1, Y54:L2, K55:L2, S96:L3, H98:L3;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>L: (FLU)300</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: D31, W33, Y56, Y101, G102, Y103; L: H31, N33, N35, Y37, H39, Y54, S96, W101</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>418.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>287.9</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

